Check Point Software Technologies ( CHKP) on Monday reported third-quarter earnings that met estimates while revenue and ...
In morning trades on the stock market today, SharkNinja stock jumped to an all-time high of 215.89. In recent trad ...
Investor's Business Daily on MSN
Palantir earnings top views. Revenue accelerates for 13th straight quarter
Palantir stock climbed amid Q3 earnings and revenue that topped consensus estimates. Sales growth accelerated for the 13th straight quarter.
Palisade Bio's phase 2b ASCENTRA-UC trial for ulcerative colitis has begun dosing, with 12-week topline results expected in Q4 2027. I rate PALI stock as Buy.
Cantor Fitzgerald raised the firm’s price target on AbbVie (ABBV) to $325 from $290 and keeps an Overweight rating on the shares. AbbVie beat lowered Q3 ...
HS is a systemic disease with significant comorbidity, which complicates care. Dr. Lev-Tov argues that published guidelines and clear referral pathways make this burden manageable for dermatologists ...
Researchers have identified KARAP (killer cell activating receptor-associated protein), the protein product of the TYROBP gene, as a macrophage-centered regulator that may shape ulcerative colitis (UC ...
Hello, everyone. This is Thomas Kudsk Larsen from the Sanofi IR team. Welcome to the third quarter 2026 results and strategy ...
The F/m Emerald Life Sciences Innovation ETF (LFSC) ranks in the 12th percentile of Morningstar’s US Fund Health category, measured against 154 funds over the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results